Treatment of Patients with Cirrhosis.

@article{Ge2016TreatmentOP,
  title={Treatment of Patients with Cirrhosis.},
  author={Phillips Ge and Bruce Allen Runyon},
  journal={The New England journal of medicine},
  year={2016},
  volume={375 8},
  pages={
          767-77
        }
}
This guide to the practical treatment of patients with cirrhosis summarizes recent developments. It includes advice on medical management, invasive procedures, nutrition, prevention, and strategies to protect the cirrhotic liver from harm. 

Figures from this paper

The Gastroenterologist's Guide to Preventive Management of Compensated Cirrhosis.

The importance of early diagnosis, outpatient management of compensated cirrhosis, early screening for potential decompensation, and patient education are reviewed.

Cirrhosis and End-Stage Liver Disease

In the chapter that follows, the management of system and specific scenarios encountered while caring for critically ill patients with severe liver disease before and after surgery are reviewed.

Assessment of Liver Function

This chapter explores various liver pathologies and their respective laboratory test abnormalities, in addition to alcohol-induced, metabolic, and cholestatic liver disease, with particular emphasis on viral hepatitis.

Management of Decompensated Cirrhosis in the Surgical ICU: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document

This Clinical Consensus Document created by the American Association for the Surgery of Trauma Critical Care Committee reviews practical clinical questions about the critical care management of patients with decompensated cirrhosis to facilitate best practices by the bedside provider.

Anticoagulation Considerations in Liver Disease

Insight is provided regarding coagulopathy of liver disease, influence on laboratory values, and anticoagulant therapy considerations for critical care nurses assuming care for patients with cirrhosis.

Stroke and Liver Cirrhosis: A Brief Review of Current Evidence

This chapter reviewed the current evidence regarding the association between liver cirrhosis and stroke, and discussed the potential mechanisms for explaining such an association, such as coagulopathy, hypoperfusion, cardiac diseases, diabetes, and dyslipidemia.

Endoscopic and Pharmacological Treatment of Esophageal Varices

Non-invasive elastography techniques offer valuable alternatives and may help to discriminate patients at high risk of developing GEVs and first episode of bleeding from low-risk subjects.

Observational study of the microcirculation in patients with liver cirrhosis

The aim of this work is to quantify the peripheral systemic microcirculatory changes associated with increasing severity of liver cirrhosis.

General Care of the Cirrhotic Patient

This chapter will describe a case of compensated cirrhosis, and address the aspects of general Cirrhosis care that are important for primary care physicians.
...

References

SHOWING 1-10 OF 62 REFERENCES

Management of hepatocellular carcinoma: An update

Since the publication of the American Association for the Study of Liver Diseases (AASLD) practice guidelines on the management of hepatocellular carcinoma (HCC) in 2005, new information has emerged

Natural history of patients hospitalized for management of cirrhotic ascites.

  • R. PlanasS. Montoliu R. Solá
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2006

Role of albumin treatment in patients with spontaneous bacterial peritonitis.

  • M. PocaM. Concepción C. Guarner
  • Medicine
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2012

Deleterious effects of beta‐blockers on survival in patients with cirrhosis and refractory ascites

The use of beta‐blockers is associated with poor survival in patients with refractory ascites, and results suggest that beta‐ blockers should be contraindicated in these patients.

Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.

Among patients with cirrhosis and SBP, NSBBs increase the proportion who are hemodynamically compromised, time of hospitalization, and risks for hepatorenal syndrome and acute kidney injury, and they also reduce transplant-free survival.

Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity

Satavaptan, alone or in combination with diuretics, is not clinically beneficial in the long-term management of ascites in cirrhosis.

Oral Antibiotic Prophylaxis Reduces Spontaneous Bacterial Peritonitis Occurrence and Improves Short-Term Survival in Cirrhosis: A Meta-Analysis

Antibiotic prophylaxis improved short-term survival in treated patients when compared with untreated control groups and reduced the overall risk of infections, including SBP, during follow-up.

Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study.

It is concluded that continuous administration of propranolol by mouth is effective in preventing recurrent gastrointestinal bleeding in patients with cirrhosis.
...